Karo Pharma AB (Karo Pharma AB) Change In Inventory : $0.0 Mil (TTM As of Jun. 2022)

View and export this data going back to . Start your Free Trial

What is Karo Pharma AB Change In Inventory?

Karo Pharma AB's change in inventory for the quarter that ended in Jun. 2022 was $0.0 Mil. It means Karo Pharma AB's inventory stayed the same from Dec. 2021 to Jun. 2022 .

Karo Pharma AB's change in inventory for the fiscal year that ended in Dec. 2021 was $-6.2 Mil. It means Karo Pharma AB's inventory increased by $6.2 Mil from Dec. 2020 to Dec. 2021 .

Karo Pharma AB's Total Inventories for the quarter that ended in Jun. 2022 was $56.0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. Karo Pharma AB's Inventory Turnover for the quarter that ended in Jun. 2022 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Karo Pharma AB Change In Inventory Historical Data

The historical data trend for Karo Pharma AB's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Karo Pharma AB Change In Inventory Chart

Karo Pharma AB Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Change In Inventory

Get a 7-Day Free Trial

-1.42

-9.09

-6.31

-10.94

-6.20

Karo Pharma AB Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Jun22
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Karo Pharma AB Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

Karo Pharma AB (OTCPK:KARBF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Karo Pharma AB's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	55.3765	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Karo Pharma AB's Inventory Turnover for the quarter that ended in Jun. 2022 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	55.3765
	=	0.00

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Karo Pharma AB's Inventory to Revenue for the quarter that ended in Jun. 2022 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	55.3765	/	0
	=	N/A

Karo Pharma AB Change In Inventory Related Terms

Thank you for viewing the detailed overview of Karo Pharma AB's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Karo Pharma AB (Karo Pharma AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Karo Pharma AB (OTCPK:KARBF) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

Klara Norra Kyrkogata 33, Stockholm, SWE, 111 22

Website

https://www.karopharma.com

Karo Pharma AB is a healthcare corporation. It is engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector. The trademarks of the firm are Ibux, Paracet, Dosett, Allevo, and Swereco. It operates in the segment of development and sale of products to pharmacies, digital distribution channels and food stores. The company carries its business operations in Sweden and internationally, of which the majority of the revenue is generated from Sweden and Norway.

Karo Pharma AB (Karo Pharma AB) Headlines

From GuruFocus

Avista Capital Partners To Sell Trimb To Karo Pharma

By PRNewswire PRNewswire • 06-25-2019